Literature DB >> 32345914

Inhibiting MLL1-WDR5 interaction ameliorates neuropathic allodynia by attenuating histone H3 lysine 4 trimethylation-dependent spinal mGluR5 transcription.

Tzer-Bin Lin1,2,3, Cheng-Yuan Lai4, Ming-Chun Hsieh4, Yu-Cheng Ho4, Hsueh-Hsiao Wang4, Po-Sheng Yang4,5, Jen-Kun Cheng4,6, Gin-Den Chen7,8, Soo-Cheen Ng7,8, Hsien-Yu Peng4.   

Abstract

ABSTRACT: Mixed lineage leukemia 1 (MLL1)-mediated histone H3 lysine 4 trimethylation (H3K4me3) of a subset of genes has been linked to the transcriptional activation critical for synaptic plasticity, but its potential contribution to neuropathic allodynia development remains poorly explored. Here, we show that MLL1, which is induced in dorsal horn neuron after spinal nerve ligation (SNL), is responsible for mechanical allodynia and increased H3K4me3 at metabotropic glutamate receptor subtype 5 (mGluR5) promoter. Moreover, SNL induced WD (Trp-Asp) repeat domain 5 subunit (WDR5) expression as well as the MLL1-WDR5 interaction accompany with H3K4me3 enrichment and transcription of mGluR5 gene in the dorsal horn in neuropathic allodynia progression. Conversely, WDR5-0103, a novel inhibitor of the MLL1-WDR5 interaction, reversed SNL-induced allodynia and inhibited SNL-enhanced mGluR5 transcription/expression as well as MLL1, WDR5, and H3K4me3 at the mGluR5 promoter in the dorsal horn. Furthermore, disrupting the expression of MLL1 or WDR5 using small interfering RNA attenuated mechanical allodynia and reversed protein transcription/expression and complex localizing at mGluR5 promoter in the dorsal horn induced by SNL. This finding revealed that MLL1-WDR5 complex integrity regulates MLL1 and WDR5 recruitment to H3K4me3 enrichment at mGluR5 promoter in the dorsal horn underlying neuropathic allodynia. Collectively, our findings indicated that SNL enhances the MLL1-WDR5 complex, which facilitates MLL1 and WDR5 recruitment to H3K4me3 enrichment at mGluR5 promoter in spinal plasticity contributing to neuropathic allodynia pathogenesis.
Copyright © 2020 International Association for the Study of Pain.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32345914     DOI: 10.1097/j.pain.0000000000001898

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  2 in total

1.  Blocking the Spinal Fbxo3/CARM1/K+ Channel Epigenetic Silencing Pathway as a Strategy for Neuropathic Pain Relief.

Authors:  Tzer-Bin Lin; Hsien-Yu Peng; Ming-Chun Hsieh; Yu-Cheng Ho; Cheng-Yuan Lai; Hsueh-Hsiao Wang; Po-Sheng Yang; Jen-Kun Cheng; Gin-Den Chen; Soo-Cheen Ng; An-Sheng Lee; Kuang-Wen Tseng
Journal:  Neurotherapeutics       Date:  2021-01-07       Impact factor: 7.620

2.  WIN site inhibition disrupts a subset of WDR5 function.

Authors:  Andrew J Siladi; Jing Wang; Andrea C Florian; Lance R Thomas; Joy H Creighton; Brittany K Matlock; David K Flaherty; Shelly L Lorey; Gregory C Howard; Stephen W Fesik; April M Weissmiller; Qi Liu; William P Tansey
Journal:  Sci Rep       Date:  2022-02-03       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.